Oct 1, 2020 | Cannabis, EAS in Action
Of interest to the hemp, CBD and cannabis industries, the US House Democratic leaders have decided to postpone voting on legislation to decriminalize marijuana at the federal level until after the November 3, 2020 election. EAS team of consultants, under leadership of...
Sep 10, 2020 | Cannabis, Seminar
As states begin to regulate legalized CBD and hemp, the concern of how Good Manufacturing Practices (GMPs) apply to these unique industries cannot be understated. While regulations vary from state to state the quality systems under which products are grown …
Aug 26, 2020 | Cannabis, Cosmetics, Dietary Supplements, Drugs, Foods, Issue of the Month, Medical Devices, Tobacco, Veterinary
When the phone rings at EAS Consulting Group lately it is very often someone seeking assistance with Good Manufacturing Practices. While COVID-19 has caused major disruptions to global supply chains and manufacturing capabilities, FDA regulated industries forged ahead…
Jan 1, 2020 | Cannabis, Cosmetics, EASeNews, Foods, Issue of the Month
By Gisela Leon, MS, MBA, Independent EAS Consultant On November 22, FDA published 15 warning letters in a “catch all” effort regarding cannabidiol products. The products range from articles sold as dietary supplements, conventional foods, cosmetics, and animal...
Feb 27, 2019 | Cannabis, EAS in the News Cannabis
Cannabis Industry Journal Hemp Products & Confusion Over FDA Remains February 27, 2019 Charlotte...
